Nedocromil Sodium

奈多罗米钠

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameNedocromil Sodium
Drug Alias Name尼多克罗nedocromilumnedocromilo来多克罗米尼多考米钠 +[18] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMast cells stabilizers
TargetsNot applicable
Therapy Area/IndicationsConjunctivitis, AllergicRhinitis, AllergicLung Diseases +[4] 
Global Approved IndicationsConjunctivitis, AllergicRhinitis, AllergicAsthma
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date1992/12/30
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusWithdrawn
Highest Status in ChinaN/A
Originator CompaniesPfizer Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesJohns Hopkins Bloomberg School Of Public HealthKing Pharmaceuticals Inc
Active IndicationsN/A
Inactive IndicationsConjunctivitis, AllergicRhinitis, AllergicLung Diseases +[4] 

Other Information

ATC CodeR01AC07R03BC03S01GX04
Related LinksWikipediaDrugBankKEGG